Literature DB >> 33211080

Assessment of Discordance Among Smoldering Multiple Myeloma Risk Models.

Elizabeth Hill1, Alexander Dew1,2, Candis Morrison1, Constance Yuan3, Maryalice Stetler-Stevenson3, Ola Landgren4, Dickran Kazandjian1.   

Abstract

Entities:  

Mesh：

Year:  2021        PMID： 33211080      PMCID： PMC7677870          DOI： 10.1001/jamaoncol.2020.5585

Source DB:  PubMed          Journal:  JAMA Oncol        ISSN： 2374-2437            Impact factor:   31.777


× No keyword cloud information.
  4 in total

1.  Smoldering multiple myeloma: evolving diagnostic criteria and treatment strategies.

Authors:  Alissa Visram; Joselle Cook; Rahma Warsame
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2021-12-10

Review 2.  Defining genomic events involved in the evolutionary trajectories of myeloma and its precursor conditions.

Authors:  Monika Chojnacka; Benjamin Diamond; Ola Landgren; Francesco Maura
Journal:  Semin Oncol       Date:  2022-01-31       Impact factor: 5.385

Review 3.  What Is New in the Treatment of Smoldering Multiple Myeloma?

Authors:  Niccolo' Bolli; Nicola Sgherza; Paola Curci; Rita Rizzi; Vanda Strafella; Mario Delia; Vito Pier Gagliardi; Antonino Neri; Luca Baldini; Francesco Albano; Pellegrino Musto
Journal:  J Clin Med       Date:  2021-01-22       Impact factor: 4.241

Review 4.  2021 European Myeloma Network review and consensus statement on smoldering multiple myeloma: how to distinguish (and manage) Dr. Jekyll and Mr. Hyde.

Authors:  Pellegrino Musto; Monika Engelhardt; Jo Caers; Niccolo' Bolli; Martin Kaiser; Niels Van de Donk; Evangelos Terpos; Annemiek Broijl; Carlos Fernández De Larrea; Francesca Gay; Hartmut Goldschmidt; Roman Hajek; Annette Juul Vangsted; Elena Zamagni; Sonja Zweegman; Michele Cavo; Meletios Dimopoulos; Hermann Einsele; Heinz Ludwig; Giovanni Barosi; Mario Boccadoro; Maria-Victoria Mateos; Pieter Sonneveld; Jesus San Miguel
Journal:  Haematologica       Date:  2021-11-01       Impact factor: 9.941
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.